Fujirebio Diagnostics Acquires CanAg Diagnostics
Union of Two Industry Leaders with Complementary Strengths To Benefit Global Diagnostics Field through Expanded Offerings and Distribution ChannelsMALVERN, Pa. – May 31, 2006 – Fujirebio Diagnostics, Inc., a world-leader in in-vitro diagnostics, today announced that it has acquired 100% of the shares and equity-related instruments of CanAg Diagnostics AB, a leading biotechnology company based in Gothenburg, Sweden. The combination of the competencies and resources of Fujirebio Diagnostics and CanAg Diagnostics, two leaders in the field of serum tumor markers and companies with complementary